Found 242 matching trials
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
PHASE3The primary purpose of this study is to assess the effect of Debio 4126 in ...
Location
Cedars Sinai Medical Center
Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients
PHASE3The primary objective of the study is to determine if Serostim® 4 mg admini...
Location
University of Alabama/Birmingham
An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)
PHASE4This is an open-label, single-arm, multicenter, Phase 4 study to explore th...
Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
PHASE3The Macimorelin Growth Hormone Stimulation Test (GHST) will be compared wit...
Location
Harbor UCLA Medical Center
National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin
N/AThe purpose of this multicenter, open-label, observational, post-marketing ...
Location
Multiple Locations
Generation of Biological Samples Positive to Somatropin for Anti-doping Control
PHASE1Background:
Somatropin, also known as recombinant growth hormone (rhGH), i...
Location
IMIM (Hospital del Mar Medical Research Institute)
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
PHASE3This study assesses the safety and tolerability of weekly TV-1106 compared ...
Location
Teva Investigational Site 13137
Growth Hormone Therapy in Osteogenesis Imperfecta
PHASE3Growth deficiency is a key feature of severe Osteogenesis Imperfecta (OI) a...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
PHASE4The objective of this study is to evaluate the efficacy and safety of recom...
Location
Hôpital Robert Debré
Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.
NADiabetes mellitus type I (DM I) is characterized by lack of endogenous insu...
Location
Institute of Clinical Medicine